Lineage Cell Therapeutics, Inc.
LCTXLineage Cell Therapeutics, Inc. is a biotechnology company focused on developing innovative regenerative therapies using pluripotent and adult-derived cell technologies. The company aims to address unmet medical needs in areas such as neurodegenerative diseases, vision loss, and oncology by advancing the development of targeted cell-based treatments.
Company News
W.P. Carey, a diversified net lease REIT, reported Q2 2025 earnings with strong revenue growth and AFFO per share, despite experiencing net income decline due to non-cash market adjustments. The company raised full-year guidance and increased quarterly dividend.
The global refrigerated warehousing market is expected to grow significantly, driven by the surge in e-commerce, particularly in the grocery and food sectors, as well as advancements in cold storage technologies and the rising demand for temperature-sensitive products.
ORBCOMM has joined the Move to -15°C campaign as a technology provider to help track and share the telematics data that will help quantify the initiative's impact. The Move to -15°C is a coalition of industry leaders committed to changing the global temperature that frozen food is stored and transported at from -18°C to -15°C, which could cut...
W.P. Carey has undergone a transformation by restructuring its real estate portfolio to make its business more resilient. The company sold off its office properties and reset its dividend, allowing it to reinvest capital into higher-quality income-producing properties. With a focus on industrial and warehouse properties, W.P. Carey is well-positi...
Cold storage giant Lineage is seeking to raise up to $3.85 billion in its initial public offering on the Nasdaq Global Select Market. The real estate investment trust is backed by private equity firm Bay Grove Capital.
